Xenon Pharmaceuticals
XENE
XENE
59 hedge funds and large institutions have $234M invested in Xenon Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.99% more ownership
Funds ownership: 64.37% → 70.37% (+6%)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Holders
59
Holding in Top 10
3
Calls
$6K
Puts
–
Top Buyers
| 1 | +$18.6M | |
| 2 | +$15.4M | |
| 3 | +$12.4M | |
| 4 |
BC
Broadfin Capital
New York
|
+$11.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.95M |
Top Sellers
| 1 | -$6.14M | |
| 2 | -$1.57M | |
| 3 | -$1.51M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$908K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$786K |